Literature DB >> 10769176

The domains of human fibronectin mediating the binding of alpha antigen, the most immunopotent antigen of mycobacteria that induces protective immunity against mycobacterial infection.

M Naito1, T Fukuda, K Sekiguchi, T Yamada.   

Abstract

We have recently shown that alpha antigen (alpha-Ag), the immunodominant antigen of mycobacteria, has a novel fibronectin (FN)-binding motif that is unique among mycobacteria [Naito, Ohara, Matsumoto and Yamada (1998) J. Biol. Chem. 273, 2905-2909]. In this study, we examined the domains of human FN that interacted with alpha-Ag. Fragments of FN generated by either proteolysis or recombinant DNA techniques were compared for their ability to bind to alpha-Ag. Fragments containing either the C-terminal heparin-binding domain or the central cell-binding domain consistently bound to alpha-Ag. The fragment of the C-terminal heparin-binding domain, upon mutation that resulted in the loss of its heparin-binding activity, could not bind with alpha-Ag. These findings suggested that the mutated site, i.e. the main heparin-binding site of FN, was also the principal site for binding to alpha-Ag. The alpha-Ag-binding domains of FN could bind whole mycobacterial bacilli, suggesting that these two domains are important contributors to mycobacterial infection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10769176      PMCID: PMC1221009     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  41 in total

1.  Differences in domain structure between human fibronectins isolated from plasma and from culture supernatants of normal and transformed fibroblasts. Studies with domain-specific antibodies.

Authors:  K Sekiguchi; A Siri; L Zardi; S Hakomori
Journal:  J Biol Chem       Date:  1985-04-25       Impact factor: 5.157

Review 2.  Fibronectin and its receptors.

Authors:  E Ruoslahti
Journal:  Annu Rev Biochem       Date:  1988       Impact factor: 23.643

3.  The antigen 85 complex vaccine against experimental Mycobacterium leprae infection in mice.

Authors:  M Naito; M Matsuoka; N Ohara; H Nomaguchi; T Yamada
Journal:  Vaccine       Date:  1999-12-10       Impact factor: 3.641

4.  The DNA sequences encoding plsB and dgk loci of Escherichia coli.

Authors:  V A Lightner; R M Bell; P Modrich
Journal:  J Biol Chem       Date:  1983-09-25       Impact factor: 5.157

5.  Domain structure of human plasma fibronectin. Differences and similarities between human and hamster fibronectins.

Authors:  K Sekiguchi; S Hakomori
Journal:  J Biol Chem       Date:  1983-03-25       Impact factor: 5.157

6.  Cloning and expression of the Mycobacterium bovis BCG gene for extracellular alpha antigen.

Authors:  K Matsuo; R Yamaguchi; A Yamazaki; H Tasaka; T Yamada
Journal:  J Bacteriol       Date:  1988-09       Impact factor: 3.490

7.  DNA:DNA reassociation analysis of Aeromonas salmonicida.

Authors:  R J Belland; T J Trust
Journal:  J Gen Microbiol       Date:  1988-02

8.  Characterization of fibronectin-binding antigens released by Mycobacterium tuberculosis and Mycobacterium bovis BCG.

Authors:  C Abou-Zeid; T L Ratliff; H G Wiker; M Harboe; J Bennedsen; G A Rook
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

9.  Specific lymphoproliferation, gamma interferon production, and serum immunoglobulin G directed against a purified 32 kDa mycobacterial protein antigen (P32) in patients with active tuberculosis.

Authors:  K Huygen; J P Van Vooren; M Turneer; R Bosmans; P Dierckx; J De Bruyn
Journal:  Scand J Immunol       Date:  1988-02       Impact factor: 3.487

10.  Pathophysiology of antigen 85 in patients with active tuberculosis: antigen 85 circulates as complexes with fibronectin and immunoglobulin G.

Authors:  S I Bentley-Hibbert; X Quan; T Newman; K Huygen; H P Godfrey
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

View more
  7 in total

Review 1.  Bacterial virulence in the moonlight: multitasking bacterial moonlighting proteins are virulence determinants in infectious disease.

Authors:  Brian Henderson; Andrew Martin
Journal:  Infect Immun       Date:  2011-06-06       Impact factor: 3.441

2.  Fibronectin attachment protein homologue mediates fibronectin binding by Mycobacterium avium subsp. paratuberculosis.

Authors:  T E Secott; T L Lin; C C Wu
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

3.  Novel mycobacteria antigen 85 complex binding motif on fibronectin.

Authors:  Chih-Jung Kuo; Hannah Bell; Ching-Lin Hsieh; Christopher P Ptak; Yung-Fu Chang
Journal:  J Biol Chem       Date:  2011-11-29       Impact factor: 5.157

4.  Mycobacterium tuberculosis binding to human surfactant proteins A and D, fibronectin, and small airway epithelial cells under shear conditions.

Authors:  Luanne Hall-Stoodley; Gayle Watts; Joy E Crowther; Ashwin Balagopal; Jordi B Torrelles; James Robison-Cox; Robert F Bargatze; Allen G Harmsen; Erika C Crouch; Larry S Schlesinger
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

5.  Fibronectin facilitates Mycobacterium tuberculosis attachment to murine alveolar macrophages.

Authors:  Rajamouli Pasula; Paul Wisniowski; William J Martin
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

6.  Importance of a N-terminal aspartate in the internalization of the neuropeptide Y Y2 receptor.

Authors:  Steven L Parker; Michael S Parker; Ying Y Wong; Renu Sah; Ambikaipakan Balasubramaniam; Floyd Sallee
Journal:  Eur J Pharmacol       Date:  2008-07-30       Impact factor: 4.432

Review 7.  Fibronectin and Its Role in Human Infective Diseases.

Authors:  Pietro Speziale; Carla Renata Arciola; Giampiero Pietrocola
Journal:  Cells       Date:  2019-11-26       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.